KRMD

KORU Medical Systems, Inc. Healthcare Medical Instruments & Supplies

9/12
Innovation Score

Patent Activity

1/3
2 patents found OK

Cash Runway

3/3
Operating cash flow positive — self-funding.
Cash on hand: $8.8M

Revenue Trajectory

2/3
Revenue: $43.3M
YoY Growth: +22.1%

Management Quality

3/3
Insider ownership: 39.9%
SBC/Revenue: 6.9%
No reverse splits detected

Key Metrics

Market Cap $192.9M
Revenue $43.3M
Revenue Growth (YoY) +22.1%
Cash on Hand $8.8M
Cash Runway Cash Flow Positive
Shares Outstanding 45.9M
Insider Ownership 39.9%
SBC / Revenue 6.9%
Sector / Industry Healthcare / Medical Instruments & Supplies

Patents (2)

Match type: OK

7-Step Risk Assessment

How KRMD maps to our micro cap methodology:

  1. Innovation Signal 2 patents identified. This suggests the company is investing in defensible IP.
  2. Cash Runway Check Cash flow positive. No dilution risk from capital raises.
  3. Revenue Trajectory +22.1% YoY growth on $43.3M revenue. Strong growth trajectory.
  4. Management Alignment Insiders hold 39.9% of shares. SBC is 6.9% of revenue.
  5. Competitive Moat Review the company's 10-K for barriers to entry: patents, network effects, switching costs, regulatory approvals. This step requires manual research.
  6. Catalyst Identification Look for upcoming catalysts: FDA decisions, contract wins, product launches, partnerships. Check recent 8-K filings and earnings transcripts.
  7. Position Sizing Micro caps carry outsized risk. Consider position sizing relative to conviction level and portfolio concentration. This is a $192.9M company.

Financial Detail

Free Cash Flow $0.9M
FCF Yield 0.5%
Return on Equity -13.7%
Debt / Equity 19.9%
Gross Margin 61.9%
Profit Margin -5.3%
Operating Margin -7.4%
Price / Book 11.41
Current Ratio 2.33
Dividend Yield None
Share Count Change (YoY) N/A
Share Count Change (3yr) N/A

Quality Flags

Low Debt FCF Positive

Free Cash Flow Trend

Insufficient Data
Consecutive Years FCF Positive 0

Disclaimer: This is an automated screening tool, not investment advice. Micro cap stocks are inherently risky with low liquidity and high volatility. The innovation score is based on publicly available data and may not reflect the full picture. Steps 5-7 of the methodology require your own research. See our full disclaimer.

Last screened: 2026-05-11